Hydrogenology
Source-linked study record

Molecular Hydrogen in Drinking Water Protects against Neurodegenerative Changes Induced by Traumatic Brain Injury

Dohi K, Kraemer BC, Erickson MA, McMillan PJ, Kovac A, Flachbartova Z, Hansen KM, Shah GN, Sheibani N, Salameh T, Banks WA. · PloS one. 2014;9(9):e108034.

PreclinicalOther formsPublished 2014Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Preclinical

Population or model

mice, mouse, tissue, rabbit used to study parkinson’s disease.

Intervention and dose

Full text reports another explicitly administered H₂ intervention. Detected intervention quantities or schedules: 3%, 5%, 45 minutes, 0.05%, 0.01%, 7 days, 0.1%, 1 hour, 1.6 mM, 1.8 ppm. · H₂-related quantities reported in the intervention passages: 3%, 5%, 45 minutes, 0.05%, 0.01%, 7 days, 0.1%, 1 hour, 1.6 mM, 1.8 ppm. Values are not combined across different experimental arms.

Duration

45 minutes

Reported result

Article-reported result excerpt (24 words maximum): “The CCI-induced increase in AT8 and Alz50 immunoreactivity is attenuated by treatment with hydrogen water.” This excerpt is not a complete result summary; consult the linked full text for all positive and null findings.

Main limitation

Preclinical evidence only; findings do not establish a treatment effect in people. Funding or grant information is reported in the full article. The article declares no conflicts of interest.

Evidence and classification

What kind of evidence is this?

Evidence type

Preclinical

Reported design

Controlled animal and cell study

Research topic

Parkinson’s disease

Administration form

Other forms

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

mice, mouse, tissue, rabbit used to study parkinson’s disease.

Sample

Preclinical study; group or assay counts reported in the full text include n=4, n=10, n=8, n=6, n=5, n=7.

Duration

45 minutes

Intervention

Full text reports another explicitly administered H₂ intervention. Detected intervention quantities or schedules: 3%, 5%, 45 minutes, 0.05%, 0.01%, 7 days, 0.1%, 1 hour, 1.6 mM, 1.8 ppm.

Hydrogen form

another explicitly administered H₂ intervention — H₂ only unless the full text explicitly reports oxygen co-delivery.

Dose or H₂ specification

H₂-related quantities reported in the intervention passages: 3%, 5%, 45 minutes, 0.05%, 0.01%, 7 days, 0.1%, 1 hour, 1.6 mM, 1.8 ppm. Values are not combined across different experimental arms.

Comparator

Control or comparison condition reported in the full article; see the linked methods for arm-specific details.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

clinical symptoms or functional scores, inflammation and cytokines, oxidative-stress and antioxidant markers, apoptosis or cell injury, histology or tissue damage, metabolic laboratory measures

Reported result

Article-reported result excerpt (24 words maximum): “The CCI-induced increase in AT8 and Alz50 immunoreactivity is attenuated by treatment with hydrogen water.” This excerpt is not a complete result summary; consult the linked full text for all positive and null findings.

Extraction completeness

The complete machine-readable article was checked for source identity, methods, intervention quantities, results, tables, funding and conflict declarations. This public record is based on the full article.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Preclinical evidence only; findings do not establish a treatment effect in people. Funding or grant information is reported in the full article. The article declares no conflicts of interest.

Applies directly to

Applies to the reported animal, cell or tissue model, not directly to patients.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 25251220 · DOI: 10.1371/journal.pone.0108034

Publisher access

A free full article is available through PubMed Central.

Extraction basis

Official PubMed/PMC full article; source identity, intervention data and declarations re-audited 25 August 2026.

Last reviewed

25 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.